Psilocybin; Board of Pharmacy to promulgate regulations.
Virginia directs its Board of Pharmacy to create regulations enabling controlled access to psilocybin, positioning the state to explore therapeutic use despite federal prohibition.
Virginia directs its Board of Pharmacy to create regulations enabling controlled access to psilocybin, positioning the state to explore therapeutic use despite federal prohibition.
HB 1347 directs Virginia's Board of Pharmacy to develop and implement regulations governing psilocybin—a controlled psychoactive compound found in certain mushrooms. The bill establishes the regulatory framework necessary for potential therapeutic or medical use of psilocybin under state law, though it does not itself legalize psilocybin use.
This bill represents a significant shift in drug policy, positioning Virginia to potentially join other states exploring psilocybin's medical applications, particularly for mental health conditions like depression and PTSD. The regulatory framework would determine how—and whether—psilocybin can be accessed, produced, and distributed within the state, affecting patients, healthcare providers, and the pharmaceutical industry.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.